{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-006227","form_type":"8-K","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2025-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.225444+00:00","generated_at":"2026-05-23T06:04:41.855979+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Tevogen Bio amends Bylaws to modify director resignation procedure for majority vote failures","bullets":["Board amended Bylaws on April 21, 2025 to alter process for director resignations when director fails to receive majority vote in uncontested election.","Amendment filed as Exhibit 3.1; no other changes to Bylaws or fiscal year announced.","Procedural governance amendment with no immediate financial or operational impact."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-006227","json":"https://secwatch.observer/filing/0001641172-25-006227.json","markdown":"https://secwatch.observer/filing/0001641172-25-006227.md","text":"https://secwatch.observer/filing/0001641172-25-006227.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000164117225006227/0001641172-25-006227-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000164117225006227/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T06:04:41.855979+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}